Search: Tilray

Tilray to Report Third Quarter 2020 Financial Results on November 9, 2020

NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the third quarter ended September 30, 2020 on Monday, November 9, 2020 after market close. The Company will host a conference call to discuss these results at 5:00 p.m. ET. Investors interested…

Why Aurora Cannabis, Canopy Growth, and Tilray Stocks Were Down 5% (and More) on Monday

For the second day running, marijuana stocks are in a funk. Shares of cannabis industry giant Canopy Growth Corporation (NYSE: CGC) fell 6% on Monday, while smaller Aurora Cannabis (NYSE: ACB) slipped 6% and Tilray (NASDAQ: TLRY) tumbled 13%. Personally, I blame Joe Biden for this — and Donald Trump, too. READ MORE: https://finance.yahoo.com/m/92f30943-a22e-3df4-8892-ba3997bb1803/why-aurora-cannabis%2C-canopy.html?.tsrc=rss

Why Marijuana Stocks Aurora Cannabis, Canopy Growth, and Tilray Are Giving Up Much of Monday’s Gains

Canadian marijuana stocks soared on Monday as investors reacted to the prospects that the U.S. election results in November could improve the prospects for the cannabis industry. Shares of Aurora Cannabis (NYSE: ACB) were falling 9.3% lower as of 11:09 a.m. EDT on Tuesday. Canopy Growth (NYSE: CGC) stock was down 5.5%, while shares of Tilray (NASDAQ: TLRY) declined 4.3%.…

420 with CNW – Tilray, Inc. (NASDAQ: TLRY) Announces Positive Research Results for Cancer Sufferers

Medical cannabis is probably one of the most controversial topics at the moment. Critics of the medical marijuana movement have claimed that there is hardly any evidence of therapeutic benefit and that the hype has far outpaced the science. On the other hand, cannabis reform activists have argued that due to its diverse medicinal properties, medical cannabis can be a…

Tilray Q2 Cannabis Revenue Slips 2% From Q1 to $30.2 Million

Tilray, Inc. Reports 2020 Second Quarter Results Revenue Increased 10% to $50.4 Million (C$69.4 Million) versus Q2 2019 Cost Savings of $13.0 Million Realized in Q2 2020 – on Pace for Total Annualized Savings of Approximately $55 Million Net Loss of ($81.7) Million increased $45.4 Million versus Q2 2019 Partially Due to Facilities Closure and […] READ MORE: https://www.newcannabisventures.com/tilray-q2-cannabis-revenue-slips-2-from-q1-to-30-2-million/

Tilray, Inc. Reports 2020 Second Quarter Results

NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, reports financial results for the second quarter ended June 30, 2020. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. “Since the beginning of 2020 we have taken bold and significant actions to…

Tilray to Report Second Quarter 2020 Financial Results on August 10, 2020

NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the second quarter ended June 30, 2020 on Monday, August 10, 2020 after market close. The Company will host a conference call to discuss these results at 5:00 p.m. ET. Investors interested…

Analyst Explains Why He’s Bearish On Tilray And Aurora Cannabis, Recommends MSOs

GLJ Research founder Gordon Johnson joined Benzinga’s PreMarket Prep show on June 23. During the discussion, Johnson weighed in on Canadian cannabis stocks, which have made a major comeback since the market bottom in March.Johnson said the best data on the Canadian cannabis market is from Stats Canada, and recent trends are not encouraging.”In March, Canadian cannabis sales skyrocketed. What…